Tech Company Financing Transactions

Redpin Therapeutics Funding Round

Redpin Therapeutics closed a $15.5 million Series A financing round on 3/26/2020. Investors included 4BIO Capital, Alexandria Venture Investments and Arkin Bio-Ventures.

Transaction Overview

Company Name
Redpin Therapeutics
Announced On
3/26/2020
Transaction Type
Venture Equity
Amount
$15,500,000
Round
Series A
Investors

4BIO Capital (Lead Investor) (Dmitry Kuzmin)

Alexandria Venture Investments

Arkin Bio-Ventures

New York Ventures

Takeda Ventures (Michael Martin)

Proceeds Purpose
The proceeds will enable Redpin to further progress the development of its groundbreaking ultra-potent ion channel based chemogenetics platform to address disorders associated with neural circuit dysfunction including epilepsy, neuropathic pain and Parkinson's disease.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 6th Ave. 3rd Floor
New York, NY 10013
USA
Phone
Undisclosed
Website
www.redpinrx.com
Email Address
[email protected]
Overview
We are a privately held, preclinical stage gene therapy company based in New York City. We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy.
Profile
Redpin Therapeutics LinkedIn Company Profile
Social Media
Redpin Therapeutics Company Twitter Account
Company News
Redpin Therapeutics News
Facebook
Redpin Therapeutics on Facebook
YouTube
Redpin Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elma Hawkins
  Elma Hawkins LinkedIn Profile  Elma Hawkins Twitter Account  Elma Hawkins News  Elma Hawkins on Facebook
Chief Scientific Officer
David Bleakman
  David Bleakman LinkedIn Profile  David Bleakman Twitter Account  David Bleakman News  David Bleakman on Facebook
Founder
Jonathan Dordick
  Jonathan Dordick LinkedIn Profile  Jonathan Dordick Twitter Account  Jonathan Dordick News  Jonathan Dordick on Facebook
Founder
Jeffrey Friedman
  Jeffrey Friedman LinkedIn Profile  Jeffrey Friedman Twitter Account  Jeffrey Friedman News  Jeffrey Friedman on Facebook
Founder
Elma Hawkins
  Elma Hawkins LinkedIn Profile  Elma Hawkins Twitter Account  Elma Hawkins News  Elma Hawkins on Facebook
Founder
Michael Kaplitt
  Michael Kaplitt LinkedIn Profile  Michael Kaplitt Twitter Account  Michael Kaplitt News  Michael Kaplitt on Facebook
Founder
Sarah Stanley
  Sarah Stanley LinkedIn Profile  Sarah Stanley Twitter Account  Sarah Stanley News  Sarah Stanley on Facebook
Founder
Scott Sternson
  Scott Sternson LinkedIn Profile  Scott Sternson Twitter Account  Scott Sternson News  Scott Sternson on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/26/2020: Fritz venture capital transaction
Next: 3/26/2020: Humio venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.